Laxxon Medical products

Laxxon Medical's SPID Technology, also known as Screen Printed Innovative Drug Technology, utilizes advanced additive manufacturing to revolutionize drug delivery systems (DDSs). This patented approach enhances the pharmacokinetic profiles of pharmaceuticals by employing sophisticated geometric internal structures alongside a strategic distribution of active ingredients. Central to SPID Technology’s innovation is its capability to manufacture diverse dosage forms including tablets, films, implants, and transdermal patches, each tailored for optimal drug formulation through novel API combinations. Its engineering allows integration of patient safety features, like QR codes, directly onto drug surfaces, facilitating secure, information-rich pharmaceutical solutions. Furthermore, SPID Technology supports scalable production from clinical trials to mass production, accommodating up to 1.5 million units daily. This cold-process technology augments solubility, reduces side effects, and enables single-dose regimens, offering an impactful stride towards better patient compliance. Overall, it creates opportunities for comprehensive, efficient, and safer pharmaceutical manufacturing.